Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results
Optinose (NASDAQ:OPTN), a pharmaceutical company specializing in ENT and allergy treatments, has scheduled its Fourth Quarter and Full Year 2024 Financial Results announcement for March 20, 2025, before market open.
The company will host a conference call and webcast at 8:00 a.m. Eastern Time on the same day, featuring the leadership team who will discuss financial results and corporate updates. Investors can access the webcast through Optinose's website investor section, while telephone participants must register in advance to receive dial-in details. A replay will be available on the company website for 60 days following the event.
Optinose (NASDAQ:OPTN), un'azienda farmaceutica specializzata in trattamenti per l'otorinolaringoiatria e le allergie, ha programmato l'annuncio dei suoi Risultati Finanziari del Quarto Trimestre e dell'Intero Anno 2024 per 20 marzo 2025, prima dell'apertura del mercato.
L'azienda ospiterà una conferenza telefonica e un webcast alle 8:00 a.m. Eastern Time lo stesso giorno, con il team di leadership che discuterà dei risultati finanziari e degli aggiornamenti aziendali. Gli investitori possono accedere al webcast attraverso la sezione investitori del sito web di Optinose, mentre i partecipanti telefonici devono registrarsi in anticipo per ricevere i dettagli per la chiamata. Una registrazione sarà disponibile sul sito web dell'azienda per 60 giorni dopo l'evento.
Optinose (NASDAQ:OPTN), una empresa farmacéutica especializada en tratamientos para ENT y alergias, ha programado el anuncio de sus Resultados Financieros del Cuarto Trimestre y del Año Completo 2024 para 20 de marzo de 2025, antes de la apertura del mercado.
La empresa llevará a cabo una conferencia telefónica y un webcast a las 8:00 a.m. Hora del Este el mismo día, con el equipo directivo que discutirá los resultados financieros y las actualizaciones corporativas. Los inversores pueden acceder al webcast a través de la sección de inversores del sitio web de Optinose, mientras que los participantes telefónicos deben registrarse con anticipación para recibir los detalles de la llamada. Una grabación estará disponible en el sitio web de la empresa durante 60 días después del evento.
Optinose (NASDAQ:OPTN), 이비인후과 및 알레르기 치료를 전문으로 하는 제약 회사는 2024년 4분기 및 연간 재무 결과 발표를 2025년 3월 20일, 시장 개장 전에 예정하고 있습니다.
회사는 같은 날 동부 표준시 기준 오전 8시에 경영진이 재무 결과 및 기업 업데이트에 대해 논의하는 컨퍼런스 콜 및 웹캐스트를 개최할 것입니다. 투자자는 Optinose 웹사이트의 투자자 섹션을 통해 웹캐스트에 접속할 수 있으며, 전화 참가자는 사전에 등록하여 전화 접속 정보를 받아야 합니다. 이벤트 후 60일 동안 회사 웹사이트에서 재생이 가능합니다.
Optinose (NASDAQ:OPTN), une entreprise pharmaceutique spécialisée dans les traitements ORL et allergiques, a programmé l'annonce de ses Résultats Financiers du Quatrième Trimestre et de l'Année Complète 2024 pour le 20 mars 2025, avant l'ouverture du marché.
L'entreprise organisera une conférence téléphonique et un webinaire à 8h00, heure de l'Est le même jour, avec l'équipe de direction qui discutera des résultats financiers et des mises à jour de l'entreprise. Les investisseurs peuvent accéder au webinaire via la section investisseurs du site Web d'Optinose, tandis que les participants par téléphone doivent s'inscrire à l'avance pour recevoir les détails de connexion. Un enregistrement sera disponible sur le site de l'entreprise pendant 60 jours suivant l'événement.
Optinose (NASDAQ:OPTN), ein Pharmaunternehmen, das auf HNO- und Allergiebehandlungen spezialisiert ist, hat die Bekanntgabe seiner Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 für 20. März 2025 vor Markteröffnung angesetzt.
Das Unternehmen wird am selben Tag um 8:00 Uhr Eastern Time eine Telefonkonferenz und einen Webcast veranstalten, bei dem das Führungsteam die Finanzergebnisse und Unternehmensaktualisierungen besprechen wird. Investoren können über den Investorenbereich der Optinose-Website auf den Webcast zugreifen, während Telefonteilnehmer sich im Voraus registrieren müssen, um die Einwahldaten zu erhalten. Eine Aufzeichnung wird 60 Tage nach der Veranstaltung auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
Conference Call and Webcast to be held March 20, 2025, at 8:00 a.m. Eastern Time
YARDLEY, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the fourth quarter and full year of 2024 and corporate updates, before market open, on Thursday, March 20, 2025.
Company to Host Conference Call
Members of the Company’s leadership team will host a conference call to discuss financial results and corporate updates. The call is scheduled to start at 8:00 a.m. Eastern Time on Thursday, March 20, 2025.
Participants may access the conference call live via webcast by visiting the Investors section of Optinose’s website at http://ir.optinose.com/event-calendar. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a personal PIN that can be used to access the call. In addition, a replay of the webcast will be available on the Company website for 60 days following the event.
About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
FAQ
When will Optinose (OPTN) release its Q4 and full-year 2024 earnings?
How can investors join Optinose's (OPTN) Q4 2024 earnings call?
What time is Optinose's (OPTN) Q4 2024 earnings conference call?
How long will Optinose's (OPTN) Q4 2024 earnings call replay be available?
